Scarica l'app Stockscreener
5.54
1.84%
0.10
Pre-mercato:
5.58
0.04
+0.72%
Paysign Inc Borsa (PAYS) Ultime notizie
PaySign's Financial Growth and Strategic Initiatives Earn Buy Rating - AInvest
PaySign, Inc. (NASDAQ:PAYS) Q2 2025 Earnings Call Transcript - MSN
Price Channel Expanding on Paysign Inc.’s ChartBuy Signal Based on Chart Analysis Confirmed - beatles.ru
Lake Street Capital Issues Positive Forecast for Paysign (NASDAQ:PAYS) Stock Price - MarketBeat
Order Flow Trends Show Accumulation in Paysign Inc.High Conviction Intraday Stock Signals Detected - beatles.ru
Paysign to Present at Oppenheimer Technology Conference - AInvest
Paysign (NASDAQ:PAYS) Issues Quarterly Earnings Results - MarketBeat
Paysign, Inc. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now - simplywall.st
Earnings Miss: Paysign, Inc. Missed EPS By 43% And Analysts Are Revising Their Forecasts - Yahoo Finance
Paysign, Inc. (NASDAQ:PAYS) Insider Matthew Louis Lanford Sells 26,367 Shares - MarketBeat
Paysign (NASDAQ:PAYS) Issues FY 2025 Earnings Guidance - MarketBeat
Paysign, Inc. (NASDAQ:PAYS) CFO Sells $215,507.64 in Stock - MarketBeat
Insider Selling: Paysign, Inc. (NASDAQ:PAYS) Insider Sells 26,521 Shares of Stock - MarketBeat
Insider Selling: Paysign, Inc. (NASDAQ:PAYS) CEO Sells 62,158 Shares of Stock - MarketBeat
Insider Selling: Paysign, Inc. (NASDAQ:PAYS) EVP Sells 14,160 Shares of Stock - MarketBeat
Paysign's Strategic Position in the Evolving Patient Affordability and Fintech Landscape - AInvest
Paysign, Inc. to Present at the Oppenheimer Technology, Internet & Communications Conference - The Globe and Mail
GSA Capital Partners LLP Has $576,000 Stock Holdings in Paysign, Inc. (NASDAQ:PAYS) - MarketBeat
What analysts say about Paysign Inc. stockHigh Yield Portfolio Ideas - thegnnews.com
Paysign Inc. Reports Record Revenue and Strategic Growth - The Globe and Mail
3 Strong Buy Tech Stocks to Watch: Ceragon Networks, Alight, and PaySign - AInvest
Despite shrinking by US$125m in the past week, Paysign (NASDAQ:PAYS) shareholders are still up 126% over 3 years - simplywall.st
With A 37% Price Drop For Paysign, Inc. (NASDAQ:PAYS) You'll Still Get What You Pay For - 富途牛牛
Paysign 2025 Q2 Earnings Net Income Surges 99.1% - AInvest
PaySign Inc Reports Record Revenue and Strategic Expansions Amid Plasma Challenges in Q2 2025 Earnings Call - AInvest
PaySign (PAYS) Analyst Rating Maintained, Price Target Raised to $10 by Lake Street - AInvest
Paysign raises 2025 revenue guidance to up to $78.5M while expanding patient affordability programs - MSN
Paysign Inc's (PAYS) Q2 2025 Earnings and Strategic Expansion into the Pharma Sector: A Catalyst for Long-Term Growth - AInvest
Paysign Inc's Strategic Shift to Patient Affordability in Pharma: How Innovative Financial Models Are Driving Sustainable Revenue Growth and Redefining Value Chains - AInvest
Paysign's Strategic Shift in Patient Affordability and Financial Models in 2025: How B2B Payment Solutions Are Reshaping the Pharma Supply Chain - AInvest
The Resilient Business Model of Paysign: How Patient Affordability Programs Are Driving 2025 Revenue Growth to $78.5M - AInvest
PaySign Inc (PAYS) Q2 2025 Earnings Call Highlights: Record Revenue and Strategic Expansions ... - Yahoo Finance
PaySign Inc (PAYS) Q2 2025 Earnings Call Highlights: Record Reve - GuruFocus
Paysign price target raised to $10 from $9 at Lake Street - TipRanks
Paysign's Revenue Surge and Strategic Shifts in Patient Affordability: How Innovative Financial Models Are Reshaping Pharma's Value Chain in 2025 - AInvest
Paysign (PAYS) Q2 Revenue Jumps 33% - The Motley Fool
Paysign (PAYS) Q2 Revenue Jumps 33% - The Globe and Mail
Paysign, Inc. SEC 10-Q Report - TradingView
Paysign's Surging Revenue and Strategic Patient Affordability Expansion: Redefining Pharma Tech for a High-Growth Future - AInvest
Paysign Q2 2025 Earnings Call Transcript - MarketBeat
Paysign Raises 2025 Revenue Guidance to $78.5M, Expands Patient Affordability Programs - AInvest
Paysign, Inc. Reports Strong Q2 2025 Growth - TipRanks
Paysign Reports Record Q2 2025 Revenue, Doubles Net Income, and Receives Bullish Analyst Predictions - AInvest
Paysign's Q2 2025 Earnings and Strategic Transformation in Healthcare Payments: A Buy Before the Next Growth Cycle - AInvest
Paysign's Strategic Surge: A Catalyst for Healthcare Fintech's Future - AInvest
PaySign CEO Mark Newcomer Sells $440K Worth of Shares - AInvest
Earnings call transcript: Paysign Q2 2025 revenue beats forecast, EPS misses - Investing.com Nigeria
Paysign’s Pharma Bet Pays Off While Plasma Lags Behind - Finimize
20.83%
3.23%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):